Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
Lancet Oncol. 2018 Feb;19(2):257-266. doi: 10.1016/S1470-2045(17)30912-9. Epub 2017 Dec 21.
Lancet Oncol. 2018.
PMID: 29276022
Free PMC article.
Clinical Trial.
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.
Kalac M, Lue JK, Lichtenstein E, Turenne I, Rojas C, Amengual JE, Sawas A, Deng C, Mapara MY, Connors JM, Kuruvilla J, O'Connor OA.
Kalac M, et al. Among authors: turenne i.
Br J Haematol. 2018 Mar;180(5):757-760. doi: 10.1111/bjh.14449. Epub 2016 Dec 16.
Br J Haematol. 2018.
PMID: 27984643
Free article.
No abstract available.
Item in Clipboard
Gemcitabine-induced pulmonary toxicity.
Chi DC, Brogan F, Turenne I, Zelonis S, Schwartz L, Saif MW.
Chi DC, et al. Among authors: turenne i.
Anticancer Res. 2012 Sep;32(9):4147-9.
Anticancer Res. 2012.
PMID: 22993376
Item in Clipboard
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.
Bussel JB, Lee CS, Seery C, Imahiyerobo AA, Thompson MV, Catellier D, Turenne IG, Patel VL, Basciano PA, Elstrom RL, Ghanima W.
Bussel JB, et al. Among authors: turenne ig.
Haematologica. 2014 Jul;99(7):1264-71. doi: 10.3324/haematol.2013.103291. Epub 2014 Apr 18.
Haematologica. 2014.
PMID: 24747949
Free PMC article.
Item in Clipboard
Cite
Cite